Objectives: Infection, inflammation and bone resorption are closely related events in apical periodontitis development. Therefore, we sought to investigate the role of cyclooxygenase (COX) in osteoclastogenesis and bone metabolism signaling in periapical bone tissue after bacterial lipopolysaccharide (LPS) inoculation into root canals.

Methodology: Seventy two C57BL/6 mice had the root canals of the first molars inoculated with a solution containing LPS from E. coli (1.0 mg/mL) and received selective (celecoxib) or non-selective (indomethacin) COX-2 inhibitor. After 7, 14, 21 and 28 days the animals were euthanized and the tissues removed for total RNA extraction. Evaluation of gene expression was performed by qRT-PCR. Statistical analysis was performed using analysis of variance (ANOVA) followed by post-tests (α=0.05).

Results: LPS induced expression of mRNA for COX-2 (Ptgs2) and PGE2 receptors (Ptger1, Ptger3 and Ptger4), indicating that cyclooxygenase is involved in periapical response to LPS. A signaling that favours bone resorption was observed because Tnfsf11 (RANKL), Vegfa, Ctsk, Mmp9, Cd36, Icam, Vcam1, Nfkb1 and Sox9 were upregulated in response to LPS. Indomethacin and celecoxib differentially modulated expression of osteoclastogenic and other bone metabolism genes: celecoxib downregulated Igf1r, Ctsk, Mmp9, Cd36, Icam1, Nfkb1, Smad3, Sox9, Csf3, Vcam1 and Itga3 whereas indomethacin inhibited Tgfbr1, Igf1r, Ctsk, Mmp9, Sox9, Cd36 and Icam1.

Conclusions: We demonstrated that gene expression for COX-2 and PGE2 receptors was upregulated after LPS inoculation into the root canals. Additionally, early administration of indomethacin and celecoxib (NSAIDs) inhibited osteoclastogenic signaling. The relevance of the cyclooxygenase pathway in apical periodontitis was shown by a wide modulation in the expression of genes involved in both bone catabolism and anabolism.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546268PMC
http://dx.doi.org/10.1590/1678-7757-2018-0641DOI Listing

Publication Analysis

Top Keywords

ctsk mmp9
12
periapical bone
8
bacterial lipopolysaccharide
8
bone resorption
8
apical periodontitis
8
bone metabolism
8
lps inoculation
8
inoculation root
8
root canals
8
gene expression
8

Similar Publications

Templated Synthesis of Hollow RuO Nanospheres for Alleviating Metal Wear Particle-Induced Osteoclast Activation and Bone Loss.

Small

December 2024

Department of Orthopedics, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210002, P. R. China.

Article Synopsis
  • The study highlights that wear debris from joint implants leads to excessive osteoclast activity, causing bone loss and implant failure in total joint surgeries.
  • Researchers developed hollow ruthenium oxide (RuO) nanospheres as an antioxidant to combat this problem by inhibiting processes that promote osteoclast formation and activity.
  • In experiments, these RuO nanospheres successfully reduced bone loss and negative tissue changes in mice exposed to harmful implant materials, suggesting potential for broader therapeutic uses in related inflammatory conditions.
View Article and Find Full Text PDF

4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production.

Int Immunopharmacol

December 2024

Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, PR China; The Key Laboratory of Orthopedic Biomechanics of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, PR China. Electronic address:

Intracellular reactive oxygen species (ROS) accumulation is key to osteoclast differentiation. Plant-derived polyphenols that have reduced ROS production have been widely studied for the treatment of osteoporosis. However, these compounds are rarely absorbed in the small intestine and are instead converted to phenolic acids by the microbiota in the colon.

View Article and Find Full Text PDF
Article Synopsis
  • - Osteoporosis is a serious condition causing weakened bones and increased fracture risk, particularly in older individuals, highlighting the need for better treatment options with fewer side effects.
  • - Trifolirhizin, a natural compound from Sophora flavescens, was studied for its effects on osteoclast formation and function, showing potential in reducing bone resorption and protecting against bone loss in mice.
  • - The research found that trifolirhizin inhibits key signaling pathways related to bone loss, suggesting it could be a promising therapeutic agent for osteoporosis and related diseases.
View Article and Find Full Text PDF

Investigating the Underlying Molecular Mechanisms of Yunke on Bone Metastases from Prostate Cancer.

Biologics

July 2024

Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Objective: To explore analgesic effect and bone repair mechanism of non-radioactive technetium-99 conjugated with methylene diphosphonate (Tc-MDP, brand name, Yunke) on bone metastases (BM).

Procedures: In vivo experiment, mouse BM models of prostate cancer RM-1 cell were constructed and divided into Control, Yunke, Tc+SnCl and MDP groups based on medicine composition. Tumor specimens were inspected for size, X-ray, microCT and histopathology.

View Article and Find Full Text PDF

Background/purpose: Osteoclast differentiation is crucial for orchestrating both tooth movement and the maintenance of bone density. Therefore, the current study sought to explore the impact of low-level laser therapy (LLLT) on osteoclast differentiation, functional gene expression, molecular signaling pathways, and orthodontic tooth movement in clinical settings.

Materials And Methods: The RAW 264.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!